Transcriptional and metabolic regulation of vaccine-elicited CD8+ T cell responses
- Institution
- UNIVERSITY OF COLORADO DENVER, CO
- Principal investigator
- Ross M Kedl
- Funding
- $461K
- Duration
- 2007–2029
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY Due to the overwhelming success of the new mRNA vaccines during the SARS-CoV2 pandemic, vaccines have entered the public consciousness to a level not seen since the days of smallpox eradication and the polio epidemic. It seems reasonable to assume that the established rules governing T cell responses to infections might be useful in developing better subunit vaccine formulations. However, there is mounting evidence that the immunological mechanisms relevant to adjuvant-elicited cellular immunity are vastly different than those observed in response to infectious challenge. Over the last 20 years, we have published extensively on a growing list of factors that highlight the mechanistic distinctions between vaccine-elicited (Tvacs) and infection-elicited (Tinf) T cell responses in mice and non-human primates. Our most recent data has revealed additional features mechanistically unique to Tvacs. Whereas Tinf split their functions between 2 different cell types and either divide or become memory, Tvacs do both within the same cell. Our data support an entirely novel model of CD8+ T cell activation whereby two transcription factors normally opposed to one another in function instead cooperate to sustain Tvacs exponential clonal expansion as well as a memory cell fate. The goals of this project will be to understand how these transcription factors cooperate instead of competing to support a vaccine-elicited T cell's transcriptional and metabolic needs.
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF COLORADO DENVER
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of Colorado DenverNot yet scored
Mechanisms of combined CD40/TLR adjuvant-elicited cellular immunity
Thomas A Adams · $597K · 2021–2026
- NIH · University of Colorado Denver70
Impact of Aiolos on intestinal intraepithelial lymphocytes
Kentaro Yomogida · $162K · 2022–2027
- NIH · University of Colorado Denver65
Administrative supplement to Exosome Biomarkers in concussion and Alzheimer's.
Ann-Charlotte Esther Granholm-Bentley · $107K · 2021–2026